A detailed history of Retirement Planning CO Of New England, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Retirement Planning CO Of New England, Inc. holds 1,029 shares of AMGN stock, worth $302,526. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,029
Previous 1,037 0.77%
Holding current value
$302,526
Previous $324,000 2.16%
% of portfolio
0.17%
Previous 0.18%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $2,475 - $2,699
-8 Reduced 0.77%
1,029 $331,000
Q2 2024

Aug 08, 2024

BUY
$262.75 - $319.31 $1,313 - $1,596
5 Added 0.48%
1,037 $324,000
Q1 2024

May 06, 2024

SELL
$268.87 - $324.56 $111,849 - $135,016
-416 Reduced 28.73%
1,032 $293,000
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $18,410 - $20,769
72 Added 5.23%
1,448 $417,000
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $56,193 - $69,765
257 Added 22.97%
1,376 $369,000
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $642 - $760
3 Added 0.27%
1,119 $248,000
Q1 2023

Apr 21, 2023

SELL
$225.79 - $275.2 $1,806 - $2,201
-8 Reduced 0.71%
1,116 $269,000
Q4 2022

Feb 03, 2023

SELL
$229.03 - $291.01 $458 - $582
-2 Reduced 0.18%
1,124 $295,000
Q3 2022

Oct 19, 2022

BUY
$224.46 - $253.15 $2,020 - $2,278
9 Added 0.81%
1,126 $253,000
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $1,845 - $2,053
-8 Reduced 0.71%
1,117 $271,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $30,478 - $33,717
-139 Reduced 11.0%
1,125 $272,000
Q4 2021

Feb 08, 2022

BUY
$198.88 - $227.6 $251,384 - $287,686
1,264 New
1,264 $284,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $157B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Retirement Planning CO Of New England, Inc. Portfolio

Follow Retirement Planning CO Of New England, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Planning CO Of New England, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Retirement Planning CO Of New England, Inc. with notifications on news.